UPB · Upstream Bio, Inc.
$6.69
-0.10 (-1.47%)
At close · Aug 28
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 11, 2026
Market Cap
$366.42M
Shares
54.77M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-23 | 7,554 | $6.59 | $49,781 |
| 2026-07-09 | 1,565 | $7.98 | $12,489 |
| 2026-07-08 | 4,421 | $7.86 | $34,749 |
| 2026-06-30 | 16,799 | $6.93 | $116,417 |
| 2026-06-29 | 773 | $6.75 | $5,218 |
| 2026-06-26 | 342 | $6.36 | $2,175 |
| 2026-06-22 | 348 | $6.25 | $2,175 |
| 2026-06-15 | 9,649 | $6.10 | $58,859 |
| 2026-06-04 | 30,472 | $7.63 | $232,501 |
Showing 1–9 of 9 settlements
Key facts
CIK
2022626
CUSIP
91678A107
13F (30d)
136 filings
135 filers
Visit website
Investor relations